| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/1996 | US5510352 Reducing side effects by administering optically pure isomer |
| 04/23/1996 | US5510351 Delta-17 and delta-20 olefinic and saturated 17 beta-substituted 4-aza-5 alpha-androstan-ones as 5 alpha reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders |
| 04/23/1996 | US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders |
| 04/23/1996 | US5510349 Retroviral protease inhibitors |
| 04/23/1996 | US5510347 Thienothiadiazine sulfonamides useful as carbonic anhydrase inhibitors |
| 04/23/1996 | US5510345 Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 04/23/1996 | US5510343 Bicyclic and tricyclic β-lactams |
| 04/23/1996 | US5510342 Method of lowering cholesterol |
| 04/23/1996 | US5510341 Ovulation-inhibiting preparation for hormonal contraception |
| 04/23/1996 | US5510340 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/23/1996 | US5510339 Method for the treatment of bronchial asthma by administration of topical anesthetics |
| 04/23/1996 | US5510336 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| 04/23/1996 | US5510335 Pre-exercise hydration with a glycerol solution |
| 04/23/1996 | US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| 04/23/1996 | US5510250 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/23/1996 | US5510119 Controlled release therapeutic system for liquid pharmaceutical formulations |
| 04/23/1996 | US5510114 Slow release pharmaceutical composition containing a bile acid as an active ingredient |
| 04/23/1996 | US5510113 Promoting hair pigmentation |
| 04/23/1996 | US5510111 Therapeutic composition remedying the disorders appearing in the otolaryngological sphere |
| 04/23/1996 | US5510104 Administering a selective alpha-amino acids or their alkyl esters in presence of halide; microbiocides; myeloperoxidase, eosinophil peroxidase |
| 04/23/1996 | US5510101 Useful in treatment of keratoconjunctivitis sicca |
| 04/23/1996 | CA2161072A1 Alkyl-5-methylsulfonylbenzoylguanidine derivatives |
| 04/23/1996 | CA2069627C Container for fan-folded sheets |
| 04/23/1996 | CA1338258C Method for producing analgesia in mammals |
| 04/21/1996 | CA2160739A1 Ketoprofen liposomes |
| 04/20/1996 | CA2160859A1 Quinoxalines, a process for their preparation, and their use |
| 04/20/1996 | CA2160763A1 Antiviral ethers of aspartate protease substrate isosteres |
| 04/18/1996 | WO1996011280A1 Attenuated viruses and method of making the same |
| 04/18/1996 | WO1996011210A1 Cyclic hexapeptides having antibiotic activity |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011206A1 Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids |
| 04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
| 04/18/1996 | WO1996011200A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | WO1996011199A1 Naphthyridinone derivatives |
| 04/18/1996 | WO1996011198A1 Naphthyridine derivatives |
| 04/18/1996 | WO1996011196A1 Pyrazolylmethyl-thiazolidines useful as hypoglycemic agents |
| 04/18/1996 | WO1996011195A1 Indole derivatives as 5ht1-like agonists |
| 04/18/1996 | WO1996011192A1 Lta4 hydrolase inhibitors |
| 04/18/1996 | WO1996011191A1 Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis |
| 04/18/1996 | WO1996011184A1 Colchicine derivatives and the therapeutical use thereof |
| 04/18/1996 | WO1996011021A2 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | WO1996011009A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
| 04/18/1996 | WO1996011008A1 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
| 04/18/1996 | WO1996011007A1 Parenteral pharmaceutical compositions containing gf120918a |
| 04/18/1996 | WO1996011006A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation |
| 04/18/1996 | WO1996011005A2 Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases |
| 04/18/1996 | WO1996011004A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 04/18/1996 | WO1996011003A1 Ophthalmic and aural compositions containing diclofenac potassium |
| 04/18/1996 | WO1996011002A1 Antiinflammatory agent for external use |
| 04/18/1996 | WO1996011001A1 Modafinil having defined particle size |
| 04/18/1996 | WO1996010999A2 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 04/18/1996 | WO1996010998A1 Anti-acne method and composition |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | WO1996010991A1 Pharmaceutical composition containing derivatives of sex hormones |
| 04/18/1996 | WO1996010925A1 A composition to increase productivity in animal production |
| 04/18/1996 | WO1996010912A1 Method for reducing unwanted cellular adhesions |
| 04/18/1996 | WO1996010910A1 Method and formulation of stimulating nitric oxide synthesis |
| 04/18/1996 | WO1996005836A3 Methods of treating cold symptoms using pentoxifylline |
| 04/18/1996 | DE4436852A1 Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung Pyrrolyl tetrahydrobenzochinoxalindione, their preparation and use |
| 04/18/1996 | DE4436509A1 Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide And alkoxy-substituted Spiroalkylamino- heterocycles, to processes for their preparation and their use as pesticides and fungicides |
| 04/18/1996 | DE19533023A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use |
| 04/18/1996 | CA2202371A1 Lta4 hydrolase inhibitors |
| 04/18/1996 | CA2202368A1 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 04/18/1996 | CA2202272A1 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2201773A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | CA2201722A1 Antiinflammatory agent for external use |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2201628A1 Parenteral pharmaceutical compositions containing gf120918a |
| 04/18/1996 | CA2201487A1 Attenuated viruses and method of making the same |
| 04/18/1996 | CA2201134A1 Ophthalmic and aural compositions containing diclofenac potassium |
| 04/18/1996 | CA2158401A1 Alkylmethylsiloxane containing gels |
| 04/17/1996 | EP0707007A1 Amino(thio)ether derivatives as CNS active agents |
| 04/17/1996 | EP0707006A1 Aroyl-piperidine derivatives |
| 04/17/1996 | EP0707005A1 Process for obtaining of procyanidolic oligomerides |
| 04/17/1996 | EP0707004A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them |
| 04/17/1996 | EP0706995A1 Use of dehydroalanine-derivatives for the protection of the skin, mucosa and/or hair against oxidative stress, cosmetic or dermatologic compositions containing them and new compounds useful therein |
| 04/17/1996 | EP0706994A1 Melatonergic agents |
| 04/17/1996 | EP0706802A2 A method of preserving ophthalmic solutions and compositions therefor |
| 04/17/1996 | EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea |
| 04/17/1996 | EP0706796A1 Dopamine reincorporation inhibitor |
| 04/17/1996 | EP0706795A2 Catechol diether compounds as inhibitors of TNF release |
| 04/17/1996 | EP0706794A1 Anti-aids pharmaceutical preparations and processes for the production thereof |
| 04/17/1996 | EP0706793A2 Use of phthalidyliden esters of carnitine and alkanoyl carnitines for the treatment of endotoxic shock |
| 04/17/1996 | EP0706792A1 Method of potentiating an immune response and compositions therefor |
| 04/17/1996 | EP0706581A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706556A1 Cleaning and disinfecting agent |
| 04/17/1996 | EP0706530A1 Liponucleotides of desoxynucleosides, their preaparation and their use as anti-viral drugs |
| 04/17/1996 | EP0706528A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 04/17/1996 | EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 04/17/1996 | EP0706524A1 Processes and intermediates for the preparation of 5- 2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 04/17/1996 | EP0706523A1 Substituted arylthioalkylthiopyridines |
| 04/17/1996 | EP0706522A1 Tetrazole derivatives having antihistaminic and antiallergic activity |
| 04/17/1996 | EP0706521A1 Novel imides |
| 04/17/1996 | EP0706517A1 Pyridazinone derivatives with pharmaceutical activity |
| 04/17/1996 | EP0706516A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 04/17/1996 | EP0706514A1 Compounds and methods for inhibition of hiv and related viruses |